改善直肠癌放疗结局:靶向缺氧诱导的放射抵抗的系统综述
本系统综述按PRISMA指南检索并注册于Prospero(CRD42023441983),纳入8项体外或体内研究、无临床试验,评估靶向缺氧诱导的放射抵抗在直肠癌中的潜在效果;二甲双胍的体内证据存在矛盾,伏立诺他、阿托伐醌和依沃福斯酰胺显示出有前景的临床前证据。
要点
- 共纳入8项研究,均为体外或体内研究,无临床试验。
- 5项研究评估直接或间接靶向缺氧的药物疗效,3项研究识别潜在靶点。
- 二甲双胍克服缺氧诱导放射抵抗的体内证据存在矛盾。
核心结论
- 直肠癌中缺氧诱导的放射抵抗值得研究,但迄今仅有少量临床前研究评估该现象。
- 本系统综述强调需进一步研究以充分理解该放射抵抗背后的机制。
- 本系统综述识别出有前景的靶点,但未来研究需优先开展更多临床前和临床研究。
研究设计与样本
- 系统综述,按PRISMA指南进行综合文献检索,研究注册于Prospero数据库(CRD42023441983)。
- 共纳入8篇文章,均为体外或体内研究,无临床试验。
主要发现
- 8项研究中,5项评估直接或间接靶向缺氧的药物疗效,3项识别潜在靶点。
- 二甲双胍克服缺氧诱导放射抵抗的体内证据存在矛盾。
- 伏立诺他、阿托伐醌和依沃福斯酰胺显示出有前景的临床前证据,可克服缺氧诱导的放射抵抗。
局限性
- 所有研究均为体外或体内研究,无临床试验。
- 迄今仅有少量临床前研究评估直肠癌中缺氧诱导的放射抵抗现象。
- 二甲双胍克服缺氧诱导放射抵抗的体内证据存在矛盾。
- 需开展更多临床前和临床研究以充分理解该放射抵抗背后的机制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Neoadjuvant radiotherapy is successfully used in rectal cancer to improve overall survival. However, treatment response is both unpredictable and variable. There is strong evidence to show that the phenomenon of tumour hypoxia is associated with radioresistance, however the mechanism(s) behind this are poorly understood. Consequently, there have only been a small number of studies evaluating methods targeting hypoxia-induced radioresistance. The purpose of this systematic review is to evaluate the potential effectiveness of targeting hypoxia-induced radioresistance in rectal cancer and provide recommendations for future research in this area. METHODS: A comprehensive literature search was performed following the PRISMA guidelines. This study was registered on the Prospero database (CRD42023441983). RESULTS: Eight articles met the inclusion criteria. All studies identified were in vitro or in vivo studies, there were no clinical trials. Of the 8 studies identified, 5 assessed the efficacy of drugs which directly or indirectly targeted hypoxia and three that identified potential targets. There was conflicting in vivo evidence for the use of metformin to overcome hypoxia induced radioresistance. Vorinostat, atovaquone, and evofosfamide showed promising preclinical evidence that they can overcome hypoxia-induced radioresistance. DISCUSSION: The importance of investigating hypoxia-induced radioresistance in rectal cancer is crucial. However, to date, only a small number of preclinical studies exist evaluating this phenomenon. This systematic review highlights the importance of further research to fully understand the mechanism behind this radioresistance. There are promising targets identified in this systematic review however, substantially more pre-clinical and clinical research as a priority for future research is needed.
引用
- Fok M, Hill R, Fowler H, et al. Enhancing radiotherapy outcomes in rectal cancer: A systematic review of targeting hypoxia-induced radioresistance. Clin Transl Radiat Oncol. 2023. PMID: 37961749. doi:10.1016/j.ctro.2023.100695
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。